Guardion Health Sciences Inc (GHSI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GHSI Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Guardion Health Sciences Inc finances operations and invests in assets.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2024)
(Mar 31 2024) (Dec 31 2023) (Sep 30 2023) (Jun 30 2023)
Assets
Cash & cash equivalent14.82
Cash & Short-term Investments14.00
Accounts receivable0.01
Inventories0.08
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.38
Total Current Assets15.29
Equipment/Property/Plant Net0.01
Other Assets, Noncurrent0.00
Total Assets15.30
Liabilities
Accounts Payable, Current AC0.11
Accrued Liabilities, Current AC0.80
Other Liabilities, Current0.01
Total Current Liabilities0.92
Total Long-term Debt0.00
Other liabilities, Noncurrent0.63
WarrantDerivativeLiabilityNonCurrent0.63
Warrant Redemption Payable0.01
Total Liabilities1.55
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock101.74
Retained Earnings / Accumulated Deficit-87.99
Other Equity0.00
Common Stockholder's Equity13.75
Total Stockholder's Equity13.75
Liabilities & Stockholder's Equity15.30
4 historic quarters locked

Sign in to unlock the full Guardion Health Sciences Inc balance sheet history.

About Guardion Health Sciences Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20240630)
  • Filed with the SEC: August 13, 2024
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-24-031604

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.